CTAG2
Chr Xcancer/testis antigen 2
Also known as: CAMEL, CT2, CT6.2, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE2B
This gene encodes a cancer-testis antigen that functions as an autoimmunogenic tumor antigen normally expressed only in testis tissue but aberrantly expressed in various cancers including melanoma, breast, bladder, and prostate cancers. The protein serves as a target for cancer immunotherapy as it can be recognized by cytotoxic T-lymphocytes. Based on the available information, CTAG2 mutations are not associated with pediatric neurological disorders, as this gene primarily functions in cancer biology and immune recognition.
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Highly tolerant — LoF variants common in population
Tolerant to missense variation
ClinVar Variant Classifications
0 submitted variants in ClinVar
Protein Context — Lollipop Plot
CTAG2 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
External Resources
Links to major genomics databases and tools